Awards and Grant Winners, Member and FSCAI Inductions, and MSCAI Ceremony

J. Dawn Dawn Abbott, MD, MSCAI

JSCAI Year in Review

Alexandra J. Lansky, M.D., MSCAI

Best of JSCAI Case Reports: Highlighting Innovation, New Techniques, and Complications

David G. Rizik, M.D., MSCAI

Defining Exercise Hemodynamics and Function After Transcatheter Aortic Valve Replacement: The DEFINE-TAVR Prospective Study

Tayyab Shah, M.D.

The Impact of Intravascular Ultrasound Use on 1-Year Outcomes After Infrapopliteal Endovascular Intervention

Daniel J Snyder, MD

First-in-Human Experience With the EnCompass F2 Filter, a Novel Cerebral Embolic Protection Device for TAVR

Tamim M. Nazif, M.D., FSCAI

Use of a Novel, Self-Expanding Coronary Sinus Reducer to Treat Symptomatic Epicardial and Microvascular Ischemic Heart Disease: Preclinical and First-in-Human Experience

Timothy D. Henry, M.D., MSCAI

EAPCI and SCAI Joint Session: ACS and Cardiogenic Shock – Where Guidelines End and Interventional Judgment Begins

Introductory Remarks

J. Dawn Dawn Abbott, MD, MSCAI

Cardiogenic Shock and ACS: Treatment Strategy Where Guidelines Diverge

Holger Thiele, MD

Ischemic Case Presentation: What Would You Do?

Alaide Chieffo, M.D.

Non-Ischemic Case Presentation: What Would You Do?

Fredy El Sakr, MD, FSCAI

Panel Discussion

Featured Clinical Science (No CME)

6-Month Outcomes of the CARPOOL Study: Radial-to-Peripheral Versus Femoral Access in Lower Extremity PAD Revascularization

Sameh Sayfo, MD, MBA, FSCAI

Outcomes of Mitral Transcatheter Edge-to-Edge Repair in Patients with Mitral Annular Calcification

Karim Al-Azizi, MD, FSCAI

North American COVID-19 Myocardial Infarction (NACMI) Registry: One-Year Follow-Up

Payam Dehghani, MD

Lipoprotein(a) Identifies Residual Cardiovascular Risk in NIH Randomized Trials

Subhash Banerjee, M.D., FSCAI

Clinical Outcomes of Blood Return During Continuous Aspiration Mechanical Thrombectomy for Pulmonary Embolism: Full Comparative Safety and Efficacy Analysis from ENGULF

Andrew J. Klein, M.D., FSCAI

Net Clinical Outcomes of Clopidogrel vs Aspirin Monotherapy After Coronary Stenting Across Bleeding Risk and Procedural Complexity

Dr. Hao-Yu Wang, MD, PhD, FSCAI

Electronic Provider Notification Mitigates Age Disparities in the Treatment of Severe Aortic Stenosis: Insights from the DETECT AS Trial

Sammy Elmariah, M.D., FSCAI

Featured Round Table with Dr. Elazer Edelman, Dr. Martin Leon, and Dr. Renu Virmani: Molecular Engineering to Bedside Innovation

Round Table Discussion

Sahil A. Parikh, MD, FSCAI

Founders' Lecture: What I Have Learned from Examination of Cases of Sudden Coronary Death

Founders' Lecture Introductory Remarks

Sahil A. Parikh, MD, FSCAI

Founders' Lecture: What I Have Learned from Examination of Cases of Sudden Coronary Death

Renu Virmani, M.D.

Hildner Lecture: How Vascular Biology and Quantum Dynamics Drove A Revolution in Cardiovascular Sciences & Intervention

Hildner Lecture Introductory Remarks

Sahil A. Parikh, MD, FSCAI

Hildner Lecture: How Vascular Biology and Quantum Dynamics Drove A Revolution in Cardiovascular Sciences & Intervention

Elazer R. Edelman, MD, Ph.D.

Keynote Presentation with Martin B. Leon, MD

Keynote Speaker Introductory Remarks

Sahil A. Parikh, MD, FSCAI

Medical Device Development: A Journey to Transform Patient’s Lives

Martin B. Leon, M.D.

Late Breaking Clinical Trials

Sirolimus Eluting Balloons for Patients with Acute Coronary Syndrome – Evidence from the SELUTION DeNovo Trial

Andy Ladwiniec, MD

Discussion

Antonio Colombo, M.D., MSCAI

AltaValve Early Feasibility Study: One-Year Outcomes with Atrial Fixation Transcatheter Mitral Valve Replacement

Konstantinos Voudris, M.D., Ph.D., FSCAI

Discussion

David J. Cohen, M.D., FSCAI

PROMISE III: 6-Month Clinical and Quality of Life Outcomes in CLTI Patients Treated with Transcatheter Arterialization of the Deep Veins

Mehdi H. Shishehbor, D.O., MPH, PhD, FSCAI

Discussion

Sahil A. Parikh, MD, FSCAI

Can Escalation Reduce Acute myocardial infarction Mortality In Cardiogenic Shock (CERAMICS)

Babar B Basir, DO, FSCAI

Trial Update: Clinically Important Subgroups from STEMI D2U

Norman Mangner

Discussion

Kate Kearney, M.D., FSCAI

Poster Session B: Imaging: CT, MR, and Non-Invasive Imaging

Coronary Computed Tomography Angiography Characteristics in Patients With Hypertrophic Cardiomyopathy With and Without Myocardial Bridging

Prabhjot Hundal, MD

Poster Session D: Cardiogenic Shock

Obstructive Sleep Apnea Is Associated With Lower Mortality, AKI, and Cardiogenic Shock in SVT Hospitalizations: Insights From the National Inpatient Sample

Dua Malik, DO

Presidential Address by J. Dawn Abbott, MD, MSCAI, President 2026-2027

Transition of Leadership and Presidential Address by J. Dawn Abbott, MSCAI, President 2026-2027

J. Dawn Dawn Abbott, MD, MSCAI

SCAI Town Hall & Hat Day Group Photo

SCAI Town Hall

Srihari S. Naidu, MD, MSCAI

Staying Ahead of AI, Challenges for Generations Y and Z

Science in Interventional Onco-Cardiology - RCT vs. Machine Learning

Dominique J Monlezun, MD, PhD, PhD, MPH

Should a CTO be Opened or not in Patients with Cancer

Bala Pushparaji, MD

Should a CTO be Opened or not in Patients with Cancer

Teodora Donisan, MD

Most Cost-Effective Strategy - “Early versus Late” Right Heart Catheterization in Patients with Cancer Admitted for Shortness of Breath

Sukhdeep Singh Basra, MD, MPH

Most Cost-Effective Strategy - “Early versus Late” Right Heart Catheterization in Patients with Cancer Admitted for Shortness of Breath

Dinu V Balanescu, MD

Peripheral Vascular Disease in Patients with Cancer – fix or Watch?

Ahmad O. Hallak, MD

Peripheral Vascular Disease in Patients with Cancer – fix or Watch?

Awad Javaid, MD, FSCAI

One Heart, two Patients, Which one Would you Pick?

Hassan Ashraf, MD

Updates and Challenges in Interventional Onco-Cardiology

Interventional Onco-Cardiology - Year in Review

Konstantinos Marmagkiolis, MD, MBA, FSCAI

Interventional Onco-Cardiology Guidelines – Why Guidelines and not Expert Consensus?

Dinu V Balanescu, MD

Culprit Versus Complete Revascularization in Patients with Cancer and ACS – is the Gain Worth the Risk?

Salman S. Allana, M.D., FSCAI

Novel Approach to Complete Revascularization in Patients with Cancer and Multivessel CAD?

Cezar A. Iliescu, MD, FSCAI

Cardiovascular Reserve and Fitness, Main Target for the Interventional Onco-Cardiologist

Konstantinos Dean Boudoulas, MD, FSCAI

Welcome to SCAI 2026 from Program Chair, Sahil Parikh, MD, FSCAI and Presidential Address by Srihari Naidu, MD, MSCAI, SCAI President 2025-2026, Award Presentations

Welcome to SCAI 2026!

Sahil A. Parikh, MD, FSCAI

Presidential Address

Srihari S. Naidu, MD, MSCAI

CAIC Remarks

Kevin Bainey, MD

SCAI Award Presentations: Helping Hearts Lifetime Service Award

Srihari S. Naidu, MD, MSCAI

Women in Innovation (SCAI WIN): Mentee/Mentor Relationship – Sponsorship Comes in all Flavors

How to be an Advocate and Sponsorship of Women Colleagues

Andrew J. Klein, M.D., FSCAI

Mentee Experience

Hannah I Chaudry, MD, FSCAI

Panel Discussion

Women in Innovations (SCAI WIN) Evening Program and Networking Reception: Women in Leadership

Review of Current Literature of Paucity of Women in Leadership (CHD)

Audrey C. Marshall, MD, FSCAI

Review of Current Literature of Paucity of Women in Leadership

Celina M. Yong, M.D.

Asking for what you Need and Negotiation in Leadership Positions

Holly Bauser, M.D., Ph.D., FSCAI

How to Become a Leader and Balance Home Responsibilities

Izaia Coylewright

Discussion & Networking Reception

Women in Innovations (SCAI WIN): Parenting as an Interventional Cardiologist: Lessons Learned From the Past and Looking Forward for Balance in the Future

Lessons Learned: What I Wish I had Done as a Younger Interventionalist as a Parent Looking Back

Frank F. Ing, M.D., MSCAI

Parenting and Outsourcing: What I’ve Learned

Katherine Kunkel, M.D., FSCAI

Family Planning and Alternate Paths to Parenthood: What Options are out There

Boskey Patel, D.O., FACC, FSCAI

Discussion

2026 Scientific Sessions

SCAI Science and Practice